MoranSlavin Profile Banner
Moran Slavin, MD Profile
Moran Slavin, MD

@MoranSlavin

Followers
110
Following
6K
Media
3
Statuses
152

HPB & Upper GI surgical oncology, MIS advocate, surgical education enthusiast. Mother of three so no hobbies (;

New York, USA
Joined December 2020
Don't wanna be here? Send us removal request.
@MoranSlavin
Moran Slavin, MD
10 days
RT @eaonc: In #ClinicalTrial EA2222/PUMP, investigators are testing #PumpChemo in addition to SOC chemo versus SOC chemo alone for patients….
0
4
0
@MoranSlavin
Moran Slavin, MD
2 months
Congratulations! @ColumbiaSurgery and @ClevelandClinic won!.
@MontefioreSurg
Montefiore Surgery
2 months
Congratulations to our rising chief residents Drs. Murthy and Iqbal on their fellowship match today! Expect great things in transplant/HPB surgery from these two!! @CCFSurgery @ColumbiaSurgery @ClevelandClinic @nyphospital @EinsteinMed
Tweet media one
0
0
5
@grok
Grok
5 days
Join millions who have switched to Grok.
232
249
2K
@MoranSlavin
Moran Slavin, MD
2 months
RT @SWexner: Serum carbohydrate antigen 19-9 greater than 100 and risk of invasive carcinoma in pancreatic intraductal papillary mucinous n….
0
10
0
@MoranSlavin
Moran Slavin, MD
2 months
RT @HalletJulie: 🇨🇦 in #eahpba2025 champions league 🏆. HELIX RCT of TXA vs placebo for hepatectomy by @PaulKaranicolas . No change in 🩸tran….
0
21
0
@MoranSlavin
Moran Slavin, MD
2 months
RT @AAFretland: Breaking news! Pump vs transplant is no longer a debate❤️. The parties (dr. Kingham and dr. Chapman) have come to agreement….
0
9
0
@MoranSlavin
Moran Slavin, MD
3 months
The struggle is real. And CD grade 3 is enough to ruin my day.
@AnnalsofSurgery
Annals of Surgery
3 months
Early-career surgeons face high vulnerability to moral injury from complications and poor outcomes. Building “protective equity” through mentorship and peer support may mitigate long-term harm.
0
0
2
@MoranSlavin
Moran Slavin, MD
3 months
RT @GIMedOnc: #ASCO2025 .📢Practice changing for Biliary Tract and Gallbladder Cancers! .GAIN trial .Neoadjuvant chemo drastically improves….
0
50
0
@MoranSlavin
Moran Slavin, MD
3 months
Great time yesterday, talking about data on minimally invasive HPB surgery and program building at grand rounds @MontefioreSurg. Thanks for having me!
Tweet media one
Tweet media two
0
1
7
@MoranSlavin
Moran Slavin, MD
4 months
RT @EAVegaMD: "It's not only the responsibility of MTB and general surgeons to include a LS in the treatment planning for patients with sta….
0
6
0
@MoranSlavin
Moran Slavin, MD
4 months
RT @ArndtVogel: Adjuvant chemotherapy compared to observation in resected biliary tract cancers: Survival meta-analysis of phase-III contro….
0
43
0
@MoranSlavin
Moran Slavin, MD
4 months
Successful first two cases of #HAIP at ⁦@MontefioreNYC⁩. Great team work #MECCC. Great support from ⁦@MontefioreSurg⁩ leadership. This essential component of contemporary multidisciplinary care for CRLM & IHC is now available in the Bronx.
0
2
18
@MoranSlavin
Moran Slavin, MD
4 months
Very true. Working towards change @MontefioreSurg surgical oncology and #MECCC.
@AnnalsofSurgery
Annals of Surgery
4 months
Despite the 'Hispanic Paradox,' hepatobiliary and gastric cancers are rising among Hispanic individuals 📈🏥. Late diagnoses and barriers to surgical care worsen outcomes. Surgeons have a role in closing these gaps.
1
1
3
@MoranSlavin
Moran Slavin, MD
5 months
An honor and a privilege. HAIP coming soon to the Bronx.
@FlavioRochaMD
Flavio G Rocha, MD, FACS, FSSO
5 months
So honored to have Dr. Nancy Kemeny give the .Blumgart Historical Lecture at #AHPBA2025. Inspiring to see the history and evolution of .#HAI⛽️ tx for mCRC and #cholangiocarcinoma. Amazed to see just a sample of the sheer # of .Surg fellows trained in this life-saving 🎁 to pts.
Tweet media one
Tweet media two
Tweet media three
Tweet media four
0
0
3
@MoranSlavin
Moran Slavin, MD
7 months
RT @Gio_Marchegiani: Neoadjuvant chemotherapy for left 👈 sided resectable PDAC. 🪡 72% of US received adjuvant.💉 NAT had better OS (53 🆚 37….
0
20
0
@MoranSlavin
Moran Slavin, MD
7 months
RT @ArndtVogel: 1st line Systemic Treatment for Initially Unresectable CRC Liver Mets.@JAMAOnc .🔎 Post Hoc of CAIRO….
0
24
0
@MoranSlavin
Moran Slavin, MD
9 months
RT @MarcBesselink: Today @JAMASurgery: long term outcomes #ESCAPE RCT: early #surgery remains superior to #endoscopy in pts w/ wide-duct #….
0
48
0
@MoranSlavin
Moran Slavin, MD
11 months
שנה. המילים לא יכולות למציאות. 🎗️.One year. Words fail to capture. #October7Massacre #BringThemHomeNow.
0
0
0
@MoranSlavin
Moran Slavin, MD
11 months
Is it settled then? No role for neoadj RT in respectable gastric adenoCA, including GEJ (Siewert 2&3), not even with 2/3 of patients receiving periop ECF and not FLOT!. TOPGEAR trial
Tweet card summary image
nejm.org
In Western countries, the current standard of care for resectable gastric cancer is perioperative chemotherapy. Preoperative chemoradiotherapy has been considered, but data are limited regarding th...
0
0
3
@MoranSlavin
Moran Slavin, MD
1 year
RT @wei_ac: Initiation of a Robotic Pancreatoduodenectomy Program using Virtual Co.
0
3
0
@MoranSlavin
Moran Slavin, MD
1 year
RT @JournalofGISurg: Do you know how many robotic hepatectomies you have to do before you overcome the learning curve? Check it out below⬇️….
0
3
0